PACS Group (PACS) Competitors $11.22 -0.14 (-1.24%) Closing price 03:59 PM EasternExtended Trading$11.45 +0.23 (+2.06%) As of 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PACS vs. GH, OPCH, RDNT, BTSG, SHC, WGS, SGRY, CON, PRVA, and ADUSShould you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), GeneDx (WGS), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), and Addus HomeCare (ADUS). These companies are all part of the "healthcare" industry. PACS Group vs. Its Competitors Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health GeneDx Surgery Partners Concentra Group Holdings Parent Privia Health Group Addus HomeCare Guardant Health (NASDAQ:GH) and PACS Group (NYSE:PACS) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations. Which has more volatility and risk, GH or PACS? Guardant Health has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Comparatively, PACS Group has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500. Do insiders and institutionals hold more shares of GH or PACS? 92.6% of Guardant Health shares are owned by institutional investors. 6.1% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is GH or PACS more profitable? PACS Group has a net margin of 0.00% compared to Guardant Health's net margin of -49.93%. Company Net Margins Return on Equity Return on Assets Guardant Health-49.93% N/A -28.95% PACS Group N/A N/A N/A Which has stronger valuation & earnings, GH or PACS? PACS Group has higher revenue and earnings than Guardant Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$739.02M9.30-$436.37M-$3.35-16.45PACS Group$3.11B0.55$112.87MN/AN/A Do analysts prefer GH or PACS? Guardant Health currently has a consensus target price of $57.50, suggesting a potential upside of 4.36%. PACS Group has a consensus target price of $34.29, suggesting a potential upside of 205.60%. Given PACS Group's higher possible upside, analysts clearly believe PACS Group is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 1 Strong Buy rating(s) 3.06PACS Group 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86 Does the media favor GH or PACS? In the previous week, Guardant Health had 3 more articles in the media than PACS Group. MarketBeat recorded 6 mentions for Guardant Health and 3 mentions for PACS Group. Guardant Health's average media sentiment score of 0.92 beat PACS Group's score of 0.24 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryGuardant Health beats PACS Group on 9 of the 14 factors compared between the two stocks. Get PACS Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PACS vs. The Competition Export to ExcelMetricPACS GroupMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$1.71B$7.45B$5.51B$20.84BDividend YieldN/A2.74%4.59%3.65%P/E RatioN/A70.7130.0328.49Price / Sales0.5529.30447.5360.41Price / CashN/A25.9324.8117.60Price / BookN/A7.848.714.67Net Income$112.87M$243.10M$3.26B$994.60M7 Day Performance-1.85%2.14%0.90%1.50%1 Month Performance-11.24%-0.74%3.65%0.49%1 Year Performance-65.38%17.65%46.29%18.07% PACS Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PACSPACS Group3.1219 of 5 stars$11.22-1.2%$34.29+205.6%-65.3%$1.71B$3.11B0.0032,433GHGuardant Health2.742 of 5 stars$44.19+6.7%$54.95+24.3%+89.0%$5.17B$739.02M-13.192,021OPCHOption Care Health4.6195 of 5 stars$28.26flat$35.75+26.5%-6.7%$4.59B$5.00B22.618,088RDNTRadNet3.1565 of 5 stars$55.77+2.0%$69.60+24.8%-1.3%$4.10B$1.87B-129.6911,021Trending NewsEarnings ReportAnalyst UpgradeBTSGBrightSpring Health Services2.0873 of 5 stars$19.36-1.4%$24.90+28.6%+79.0%$3.45B$11.27B62.4535,000SHCSotera Health1.0429 of 5 stars$11.28+1.2%$16.00+41.8%-3.4%$3.16B$1.10B141.023,000Earnings ReportWGSGeneDx2.713 of 5 stars$108.35+6.6%$101.63-6.2%+237.6%$2.90B$362.32M2,167.001,200SGRYSurgery Partners2.8531 of 5 stars$22.22+4.4%$33.33+50.0%-23.5%$2.73B$3.11B-14.5215,000Earnings ReportCONConcentra Group Holdings Parent2.9319 of 5 stars$19.79+1.6%$28.50+44.0%-6.4%$2.50B$1.90B14.7711,250Earnings ReportDividend AnnouncementPRVAPrivia Health Group3.7813 of 5 stars$19.47+3.2%$28.38+45.8%+6.5%$2.30B$1.74B162.261,140Earnings ReportAnalyst ForecastADUSAddus HomeCare4.9093 of 5 stars$106.96+1.9%$142.57+33.3%-10.2%$1.93B$1.15B24.1449,703Analyst Revision Related Companies and Tools Related Companies GH Alternatives OPCH Alternatives RDNT Alternatives BTSG Alternatives SHC Alternatives WGS Alternatives SGRY Alternatives CON Alternatives PRVA Alternatives ADUS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:PACS) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredElon Musk: “Nothing happens without this…”Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...Behind the Markets | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PACS Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PACS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access